Case Report: Longitudinal Extensive Transverse Myelitis With Novel Autoantibodies Following Two Rounds of Pembrolizumab

A 63-year-old male with metastatic non-small cell lung cancer developed longitudinal extensive transverse myelitis (LETM) following two cycles of Pembrolizumab, an immune checkpoint inhibitor (ICI) targeting the programmed cell death receptor 1 (PD-1). Magnetic resonance imaging (MRI) showed centrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Charabi, Salma, Engell-Noerregaard, Lotte, Nilsson, Anna Christine, Stenör, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119990/
https://www.ncbi.nlm.nih.gov/pubmed/33995251
http://dx.doi.org/10.3389/fneur.2021.655283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119990/
https://www.ncbi.nlm.nih.gov/pubmed/33995251
http://dx.doi.org/10.3389/fneur.2021.655283

Ejemplares similares